{"created":"2022-02-01T06:38:34.282840+00:00","id":2011226,"links":{},"metadata":{"_buckets":{"deposit":"54e732e8-a357-4715-97a6-db3fcadde08b"},"_deposit":{"id":"2011226","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"2011226"},"status":"published"},"_oai":{"id":"oai:u-ryukyu.repo.nii.ac.jp:02011226","sets":["1642838163960:1642838338003","1642838403551:1642838407795"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_1551255647225":"Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T cell Leukemia/ Lymphoma : Insight into Autoinflammatory Diseases","subitem_1551255648112":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Morichika, Kazuho","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Tomoyose, Takeaki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Hanashiro, Taeko","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Shimabukuro, Natsuki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Tamaki, Keita","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Tedokon, Iori","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Nishi, Yukiko","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Nakachi, Sawako","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Karube, Ken-nosuke","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Fukushima, Takuya","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Katoh, Takeharu","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ohshima, Koichi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Masuzaki, Hiroaki","creatorNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_1522299639480":"open access","subitem_1600958577026":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_1522650717957":"en","subitem_1522651041219":"Creative Commons Attribution-NonCommercial-NoDerivatives 4.0"},{"subitem_1522650717957":"en","subitem_1522650727486":"https://creativecommons.org/licenses/by-nc-nd/4.0/","subitem_1522651041219":"https://creativecommons.org/licenses/by-nc-nd/4.0/"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_1522299896455":"en","subitem_1522300014469":"Other","subitem_1523261968819":"adult T cell leukemia/lymphoma (ATL)"},{"subitem_1522299896455":"en","subitem_1522300014469":"Other","subitem_1523261968819":"C-C chemokine receptor type 4 (CCR4)"},{"subitem_1522299896455":"en","subitem_1522300014469":"Other","subitem_1523261968819":"regulatory T cell (Treg)"},{"subitem_1522299896455":"en","subitem_1522300014469":"Other","subitem_1523261968819":"psoriasis vulgaris"},{"subitem_1522299896455":"en","subitem_1522300014469":"Other","subitem_1523261968819":"autoinflammatory disease"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"Adult T cell leukemia / lymphoma (ATL) is one of the most aggressive hematological malignancies caused by human T-lymphotropic virus type-I (HTLV-1). Mogamulizumab is a new defucosylated humanized monoclonal antibody agent which targets C-C chemokine receptor type 4 (CCR4) expressed occasionally on the surface of ATL cells. However, adverse events such as drug eruptions have also been highlighted, at least in part, via the dysfunction of regulatory T cells (Tregs). We herein report a pronounced recurrence of systemic psoriasis vulgaris accompanied by the treatment of mogamulizumab in a patient with ATL. Pathological examinations may suggest a mechanistic link between the recurrence of autoinflammatory diseases and anti-CCR4 antibody therapies.","subitem_description_type":"Other"},{"subitem_description":"論文","subitem_description_type":"Other"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_1522300295150":"en","subitem_1522300316516":"The Japanese Society of Internal Medicine"},{"subitem_1522300295150":"ja","subitem_1522300316516":"一般社団法人　日本内科学会"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_1551255818386":"eng"}]},"item_1617186783814":{"attribute_name":"Identifier","attribute_value_mlt":[{"subitem_identifier_type":"HDL","subitem_identifier_uri":"http://hdl.handle.net/20.500.12000/47234"}]},"item_1617186920753":{"attribute_name":"Source Identifier","attribute_value_mlt":[{"subitem_1522646500366":"ISSN","subitem_1522646572813":"1349-7235"},{"subitem_1522646500366":"ISSN","subitem_1522646572813":"0918-2918"}]},"item_1617186941041":{"attribute_name":"Source Title","attribute_value_mlt":[{"subitem_1522650068558":"en","subitem_1522650091861":"Internal Medicine"}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2016","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"10","bibliographicPageEnd":"1349","bibliographicPageStart":"1345","bibliographicVolumeNumber":"55"}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_1522305645492":"VoR","subitem_1600292170262":"http://purl.org/coar/version/c_970fb48d4fbd8a85"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_1522306287251":{"subitem_1522306382014":"DOI","subitem_1522306436033":"https://doi.org/10.2169/internalmedicine.55.5997"}},{"subitem_1522306287251":{"subitem_1522306382014":"DOI","subitem_1522306436033":"https://doi.org/10.2169/internalmedicine.55.5997"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","filename":"55_55.5997.pdf","mimetype":"application/pdf","url":{"objectType":"fulltext","url":"https://u-ryukyu.repo.nii.ac.jp/record/2011226/files/55_55.5997.pdf"},"version_id":"90818c15-76c7-4f3d-84c8-886612d5ad96"}]},"item_title":"Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T cell Leukemia/ Lymphoma : Insight into Autoinflammatory Diseases","item_type_id":"15","owner":"1","path":["1642838338003","1642838407795"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2020-11-16"},"publish_date":"2020-11-16","publish_status":"0","recid":"2011226","relation_version_is_last":true,"title":["Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T cell Leukemia/ Lymphoma : Insight into Autoinflammatory Diseases"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-08-03T05:43:09.603045+00:00"}